Mesenchymal stem cells induce endothelial cell quiescence and promote capillary formation. 2014

Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa

BACKGROUND Rapid establishment of functional blood vessels is a prerequisite for successful tissue engineering. During vascular development, endothelial cells (ECs) and perivascular cells assemble into a complex regulating proliferation of ECs, vessel diameter and production of extracellular matrix proteins. The aim of this study was to evaluate the ability of mesenchymal stem cells (MSCs) to establish an endothelial-perivascular complex in tissue-engineered constructs comprising ECs and MSCs. METHODS Primary human ECs and MSCs were seeded onto poly(L-lactide-co-1,5-dioxepan-2-one) (poly(LLA-co-DXO)) scaffolds and grown in dynamic culture before subcutaneous implantation in immunocompromised mice for 1 and 3 weeks. Cellular activity, angiogenic stimulation and vascular assembly in cell/scaffold constructs seeded with ECs or ECs/MSCs in a 5:1 ratio was monitored with real-time RT-PCR, ELISA and immunohistochemical microscopy analysis. RESULTS A quiescent phenotype of ECs was generated, by adding MSCs to the culture system. Decreased proliferation of ECs, in addition to up-regulation of selected markers for vascular maturation was demonstrated. Baseline expression of VEGFa was higher for MSCs compared with EC (P<0.001), with subsequent up-regulated VEGFa-expression for EC/MSC constructs before (P<0.05) and after implantation (P<0.01). Furthermore, an inflammatory response with CD11b+cells was generated from implantation of human cells. At the end of the 3 week experimental period, a higher vascular density was shown for both cellular constructs compared with empty control scaffolds (P<0.01), with the highest density of capillaries being generated in constructs comprising both ECs and MSCs. CONCLUSIONS Induction of a quiescent phenotype of ECs associated with vascular maturation can be achieved by co-seeding with MSCs. Hence, MSCs can be appropriate perivascular cells for tissue-engineered constructs.

UI MeSH Term Description Entries
D010982 Platelet-Derived Growth Factor Mitogenic peptide growth hormone carried in the alpha-granules of platelets. It is released when platelets adhere to traumatized tissues. Connective tissue cells near the traumatized region respond by initiating the process of replication. Platelet Derived Growth Factor,Factor, Platelet-Derived Growth,Growth Factor, Platelet-Derived
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016220 Fibroblast Growth Factor 1 A 17-kDa single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. It binds to HEPARIN, which potentiates its biological activity and protects it from proteolysis. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages, and also has chemotactic and mitogenic activities. It was originally named acidic fibroblast growth factor based upon its chemical properties and to distinguish it from basic fibroblast growth factor (FIBROBLAST GROWTH FACTOR 2). Acidic Fibroblast Growth Factor,Class I Heparin-Binding Growth Factor,Fibroblast Growth Factor, Acidic,HBGF-1,Heparin-Binding Fibroblast Growth Factor Class I,Heparin-Binding Growth Factor, Class I,FGF-1,FGF1,Fibroblast Growth Factor-1,Heparin Binding Growth Factor, Class I
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse
D016688 Mice, Inbred NOD A strain of non-obese diabetic mice developed in Japan that has been widely studied as a model for T-cell-dependent autoimmune insulin-dependent diabetes mellitus in which insulitis is a major histopathologic feature, and in which genetic susceptibility is strongly MHC-linked. Non-Obese Diabetic Mice,Mice, NOD,Mouse, Inbred NOD,Mouse, NOD,Non-Obese Diabetic Mouse,Nonobese Diabetic Mice,Nonobese Diabetic Mouse,Diabetic Mice, Non-Obese,Diabetic Mice, Nonobese,Diabetic Mouse, Non-Obese,Diabetic Mouse, Nonobese,Inbred NOD Mice,Inbred NOD Mouse,Mice, Non-Obese Diabetic,Mice, Nonobese Diabetic,Mouse, Non-Obese Diabetic,Mouse, Nonobese Diabetic,NOD Mice,NOD Mice, Inbred,NOD Mouse,NOD Mouse, Inbred,Non Obese Diabetic Mice,Non Obese Diabetic Mouse
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D045164 Mesenchymal Stem Cell Transplantation Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Stem Cell Transplantation, Mesenchymal,Transplantation, Mesenchymal Stem Cell

Related Publications

Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
November 2022, Advanced science (Weinheim, Baden-Wurttemberg, Germany),
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
January 2012, PloS one,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
May 2016, Journal of lipid research,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
January 2010, Medecine sciences : M/S,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
May 2010, Medecine sciences : M/S,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
January 2007, Endothelium : journal of endothelial cell research,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
August 2018, Journal of cellular and molecular medicine,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
May 2024, FEBS open bio,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
September 2008, Diabetes,
Torbjorn O Pedersen, and Anna L Blois, and Ying Xue, and Zhe Xing, and Yang Sun, and Anna Finne-Wistrand, and James B Lorens, and Inge Fristad, and Knut N Leknes, and Kamal Mustafa
September 2008, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!